Bausch + Lomb Corp.

11/18/2025 | Press release | Archived content

Bausch + Lomb to Participate in Citi Global Healthcare Conference

Bausch + Lomb to Participate in Citi Global Healthcare Conference

NOVEMBER 18, 2025

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and Executive Vice President and Chief Financial Officer Sam Eldessouky will participate in a fireside chat at the 2025 Citi Global Healthcare Conference on Wednesday, Dec. 3, 2025, at 9:00 a.m. ET.

A live webcast, as well as a post-event recording, will be available on the Investor Relations page of the Bausch + Lomb website: http://ir.bausch.com/investors/events-presentations.

About Bausch + Lomb
Our mission is simple - we help people see better to live better, all over the world. For nearly two centuries we've evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we're turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

© 2025 Bausch + Lomb.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251118094841/en/

Media Contact:

Chris Clark

[email protected]

(848) 360-1100

Investor Contact:

George Gadkowski

[email protected]

(877) 354-3705 (toll free)

Source: Bausch + Lomb Corporation

Bausch + Lomb Corp. published this content on November 18, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 18, 2026 at 07:30 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]